ALS2 Antikörper (AA 390-470)
Kurzübersicht für ALS2 Antikörper (AA 390-470) (ABIN7227272)
Target
Alle ALS2 Antikörper anzeigenReaktivität
Wirt
Klonalität
Konjugat
Applikation
-
-
Bindungsspezifität
- AA 390-470
-
Verwendungszweck
- ALS2 Polyclonal Antibody
-
Spezifität
- The antibody detects endogenous levels of ALS2 protein
-
Aufreinigung
- The antibody was affinity-purified from rabbit serum by affinity-chromatography using specific immunogen
-
Immunogen
- Synthesized peptide derived from part region of human ALS2 protein at AA range: 390-470
-
Isotyp
- IgG
-
-
-
-
Applikationshinweise
- Optimal working dilutions should be determined experimentally by the investigator. Suggested starting dilutions are as follows: WB (1:500-1:2000), ELISA (1:5000-1:20000).
-
Kommentare
-
Primary Antibody
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Liquid
-
Konzentration
- 1 mg/mL
-
Buffer
- PBS, pH 7.4, containing 0.02 % Sodium Azide as preservative and 50 % Glycerol.
-
Konservierungsmittel
- Sodium azide
-
Vorsichtsmaßnahmen
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Lagerung
- -20 °C
-
Informationen zur Lagerung
- Stable for one year at -20°C from date of shipment. For maximum recovery of product, centrifuge the original vial after thawing and prior to removing the cap. Aliquot to avoid repeated freezing and thawing.
-
-
- ALS2 (Amyotrophic Lateral Sclerosis 2 (Juvenile) (ALS2))
-
Andere Bezeichnung
- ALS2
-
Hintergrund
- Rabbit Anti-ALS2 Polyclonal Antibody,Alsin, Amyotrophic lateral sclerosis 2 chromosomal region candidate gene 6 protein, Amyotrophic lateral sclerosis 2 protein,ALS2 (ALS2, Alsin Rho Guanine Nucleotide Exchange Factor) is a Protein Coding gene. Diseases associated with ALS2 include Primary Lateral Sclerosis, Juvenile and Spastic Paralysis, Infantile Onset Ascending. Among its related pathways are RAB GEFs exchange GTP for GDP on RABs and Vesicle-mediated transport.,ALS2
-
Gen-ID
- 57679
-
UniProt
- Q96Q42
-
Pathways
- Skeletal Muscle Fiber Development
Target
-